The Discounted Cash Flow (DCF) valuation of Exagen Inc (XGN) is (16.85) USD. With the latest stock price at 2.68 USD, the upside of Exagen Inc based on DCF is -728.9%.
Based on the latest price of 2.68 USD and our DCF valuation, Exagen Inc (XGN) is a sell. selling XGN stocks now will result in a potential gain of 728.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 8.9% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (58.78) - (10.14) | (16.85) |
| Upside | -2293.4% - -478.2% | -728.9% |